SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-16-435849
Filing Date
2016-01-22
Accepted
2016-01-22 17:24:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d104755dsc13da.htm SC 13D/A 34036
2 EX-99.7.12 d104755dex99712.htm EX-99.7.12 61383
3 GRAPHIC g104755g39h75.jpg GRAPHIC 9206
  Complete submission text file 0001193125-16-435849.txt   104155
Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101
Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300
ACUCELA INC. (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88011 | Film No.: 161356942
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACUCELA, INC. 1301 SECOND AVE., SUITE 1900 SEATTLE WA 98101
Business Address
KUBOTA RYO (Filed by) CIK: 0001598575 (see all company filings)

Type: SC 13D/A